Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LabVax 3(22)-23 |
Trade Name | |
Synonyms | LabVax |
Drug Descriptions |
LabVax 3(22)-23 is a vaccine comprising four Labyrinthin-based peptides, which potentially induces an antitumor immune response (J Clin Oncol 41, 2023 (suppl 16; e14660)). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C182128 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LabVax 3(22)-23 | LabVax 3(22)-23 | 0 | 0 |
LabVax 3(22)-23 + Pembrolizumab + Sargramostim | LabVax 3(22)-23 Pembrolizumab Sargramostim | 0 | 1 |
LabVax 3(22)-23 + Sargramostim | LabVax 3(22)-23 Sargramostim | 0 | 1 |